Actively Recruiting
Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae
Led by Ain Shams University · Updated on 2024-08-23
60
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.
CONDITIONS
Official Title
Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primigravidae with full-term pregnancy undergoing vaginal delivery with episiotomy
- Singleton pregnancies with vertex cephalic fetus
- Women in the active phase of the first stage of labor
You will not qualify if you...
- History of allergy to lignocaine or bupivacaine
- Use of epidural or spinal anesthesia during vaginal delivery
- Local infection at the injection site
- Inability to cooperate with study procedures
- Patient refusal to participate
- Intraoperative complications affecting outcomes (e.g., bleeding, organ injury)
- Neurological disorders or chronic pain conditions
- History of drug abuse or tolerance to analgesics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ain Shams University
Cairo, Egypt
Actively Recruiting
Research Team
M
Mostafa M El Bukhari, MBBCH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here